Can essential oils help manage multiple sclerosis symptoms. How do essential oils work for MS. What are the potential benefits and risks of using essential oils for multiple sclerosis. Which essential oils are most effective for MS symptoms.

Understanding Essential Oils and Their Potential Role in MS Management

Essential oils have gained popularity as natural remedies for various health conditions, including multiple sclerosis (MS). These concentrated plant extracts are believed to capture the essence and therapeutic properties of their source plants. While scientific evidence supporting their use in MS management is limited, some studies suggest potential benefits for certain symptoms associated with the condition.

What are essential oils?

Essential oils are highly concentrated plant extracts obtained through distillation or cold pressing. They are typically combined with carrier oils for use in aromatherapy or topical applications. Popular essential oils include:

• Chamomile
• Jasmine
• Lavender
• Lemon
• Peppermint
• Rose
• Sandalwood
• Tea tree

These oils are believed to stimulate the limbic system, the part of the brain responsible for regulating mood, breathing, heart rate, and blood pressure, when inhaled or applied to the skin.

Potential Benefits of Essential Oils for MS Symptoms

While research on essential oils specifically for MS is limited, some studies have explored their potential benefits for managing symptoms often associated with the condition.

Cognitive Function and Memory

A small study published in the Journal of Medicine and Life in 2021 found that inhalation aromatherapy with lavender essential oil improved working memory in women with MS. However, it’s important to note that this study requires further validation through larger, higher-quality research.

Anxiety and Depression

Essential oils such as chamomile, jasmine, lavender, rose, and sandalwood are often used to alleviate stress, calm nerves, and boost mood. These effects may be beneficial for MS patients experiencing anxiety or depression, which are common comorbidities.

Sleep Quality

A study published in Nursing in Critical Care in 2017 demonstrated that lavender aromatherapy improved sleep quality and reduced anxiety in people with coronary artery disease. While this study didn’t specifically focus on MS patients, improved sleep quality could potentially benefit those with the condition.

Pain Management

Some essential oils, including peppermint, lavender, frankincense, and vanilla, have shown potential in pain management. A review published in the International Journal of Molecular Sciences in 2017 suggested that these oils may have “therapeutic potential” for various pain conditions. However, it’s crucial to note that most studies in this review were conducted on animals, not humans.

Limitations and Considerations in Essential Oil Research for MS

Despite the potential benefits, it’s important to approach the use of essential oils for MS management with caution. Dr. Vijayshree Yadav, a neurologist at Oregon Health and Science University, emphasizes that the use of essential oils in MS treatment hasn’t been well-studied.

Moreover, many studies on essential oils have been conducted on animals rather than humans. As Dr. Yadav points out, “It’s a big leap to say that these oils work well in mice so they must work just as well in humans.” This highlights the need for more robust, human-based research to establish the efficacy of essential oils in MS management.

Safety Considerations and Potential Risks of Essential Oils

While essential oils are often perceived as natural and therefore safe, it’s crucial to understand that they can pose risks if used improperly.

Regulation and Quality Control

The essential oil industry is largely unregulated, which means the quality and purity of products can vary significantly. This lack of standardization makes it challenging to ensure consistent therapeutic effects and safety across different brands or batches.

Proper Usage

Essential oils are not intended for oral consumption and can be dangerous if swallowed. They should only be used for inhalation or, in some cases, topical application when properly diluted with a carrier oil.

Potential Side Effects

Some individuals may experience allergic reactions or skin irritation when using essential oils topically. It’s always advisable to perform a patch test before applying any new oil to a larger area of skin.

Integrating Essential Oils into MS Management: A Holistic Approach

While essential oils should not replace conventional MS treatments, some individuals find them helpful as part of a complementary approach to managing their symptoms. Mary Ellen Ciganovich, an author and educator specializing in holistic healing who has MS herself, states, “Anything natural that helps keep my MS monster in its cave is very useful.”

Ciganovich manages her MS through a combination of diet, exercise, meditation, herbs, and essential oils. This holistic approach demonstrates how essential oils can be integrated into a comprehensive MS management strategy.

Consultation with Healthcare Providers

Before incorporating essential oils into your MS management routine, it’s crucial to consult with your healthcare provider. They can help you understand potential interactions with your current medications and ensure that the use of essential oils aligns with your overall treatment plan.

Promising Essential Oils for MS Symptom Management

While more research is needed to conclusively determine the efficacy of essential oils for MS, some oils have shown potential benefits for managing common MS symptoms:

1. Lavender: May help with sleep quality, anxiety, and cognitive function
2. Peppermint: Potentially beneficial for pain management and digestive issues
3. Frankincense: May help with inflammation and pain
4. Chamomile: Known for its calming properties, potentially helpful for stress and anxiety
5. Rosemary: Some studies suggest potential benefits for cognitive function

Future Directions in Essential Oil Research for MS

As interest in complementary and alternative therapies for MS grows, there is a need for more rigorous scientific research on the potential benefits and risks of essential oils. Future studies should focus on:

• Large-scale, randomized controlled trials specifically targeting MS patients
• Long-term safety and efficacy assessments of essential oil use in MS management
• Standardization of essential oil quality and dosing for research purposes
• Exploration of potential interactions between essential oils and conventional MS treatments
• Investigation of the mechanisms by which essential oils may affect MS symptoms

As research progresses, we may gain a clearer understanding of how essential oils can be safely and effectively integrated into comprehensive MS management strategies.

Practical Tips for Using Essential Oils Safely with MS

If you’re considering incorporating essential oils into your MS management routine, here are some practical tips to ensure safe and effective use:

Choose High-Quality Oils

Look for reputable brands that provide detailed information about their sourcing and production methods. Organic, therapeutic-grade oils are often considered the highest quality.

Proper Dilution

Always dilute essential oils with a carrier oil before applying them to your skin. A general rule of thumb is to use 2-3 drops of essential oil per teaspoon of carrier oil.

Patch Testing

Before using a new essential oil, perform a patch test on a small area of skin to check for any adverse reactions.

Inhalation Methods

Use a diffuser to disperse essential oils into the air, or add a few drops to a tissue or cotton ball for personal inhalation. Be mindful of the duration and frequency of use to avoid overexposure.

Storage

Store essential oils in dark glass bottles in a cool, dry place away from direct sunlight to preserve their potency and prevent degradation.

Educate Yourself

Learn about the properties and potential effects of different essential oils. Understanding their individual characteristics can help you choose the most appropriate oils for your specific symptoms.

Monitor Your Response

Keep track of how you feel when using essential oils. If you notice any adverse effects or worsening of symptoms, discontinue use and consult your healthcare provider.

By following these guidelines and working closely with your healthcare team, you can explore the potential benefits of essential oils as a complementary approach to managing your MS symptoms while minimizing risks.

Can Essential Oils Help Manage Multiple Sclerosis?

Essential oils are plant extracts designed to capture the “essence,” or scent, of the original plant.

Examples of popular essential oils include:

• Chamomile
• Jasmine
• Lavender
• Lemon
• Peppermint
• Rose
• Sandalwood
• Tea tree

These essences are typically compounded and sold as natural remedies for a variety of conditions. They are most often used in the practice of aromatherapy, which today is considered a form of complementary or alternative medicine with roots in ancient civilizations in Asia as well as in the Mediterranean region.

Scientific evidence for the medicinal benefits of these products is limited. But some studies have found they help manage fatigue, anxiety, cognitive problems, skin disorders, digestive problems, and headaches, among other symptoms.

Although little research has been done on the possible benefits of essential oils for multiple sclerosis (MS), one recent study suggests lavender may improve memory problems in people who have MS (these results are preliminary and moderate to low quality, and require additional studies and validation).

Others believe essential oils can help people with the condition manage pain, fatigue, and digestive problems, as well as other health conditions often linked with MS, like depression and anxiety.

“Anything natural that helps keep my MS monster in its cave is very useful,” says Mary Ellen Ciganovich, an author and educator who specializes in holistic healing and has MS herself. “I handle my own MS through diet, exercise, meditation, herbs, and essential oils, and I recommend these approaches to others with the condition.”

So how can essential oils help you — if at all?

What Are Essential Oils?

Essential oils are collected from the source plants through several processes, including distillation (using steam) or cold pressing. Once extracted from the plant, the oils are combined with a “carrier” oil to create the final product.

It’s important to note that essential oils aren’t intended to be taken orally. In fact, swallowing them may be dangerous.

Instead, they are designed to be inhaled or, in some cases, applied to your skin.

It’s believed that inhaling the aromas of essential oils can stimulate areas of your limbic system, the part of your brain that regulates mood as well as breathing, heart rate, and blood pressure.

The effect of essential oils on the limbic system is what gives them their medicinal qualities.

How Essential Oils Might Help Symptoms Related to MS

To date, the use of essential oils in the treatment of MS itself hasn’t been well studied, according to Vijayshree Yadav, MD, a neurologist at Oregon Health and Science University in Portland. But symptoms have been addressed in research.

A study published in the November–December 2021 Journal of Medicine and Life found that inhalation aromatherapy with lavender essential oil improved working memory in women with multiple sclerosis (this small study requires further validation through larger and higher-quality studies). Cognitive changes, including memory problems, are common in MS, according to the National Multiple Sclerosis Society (NMSS).

Essential oils may also treat other health problems often linked to MS.

For example, anxiety and depression are behavioral health conditions that are common in people with MS. Several essential oils — including chamomile, jasmine, lavender, rose, and sandalwood — are used to calm nerves, relieve stress, and boost mood.

A study of aromatherapy using lavender published in the March 2017 issue of the journal Nursing in Critical Care found that the essential oil improved sleep quality and reduced anxiety in people with coronary artery disease.

In addition, a review published in May 2017 in Frontiers in Aging Neuroscience suggested that aromatherapy with essential oils — including lavender and rosemary — improved cognitive function and slowed the progression of memory loss in people with Alzheimer’s disease and dementia. Cognitive function problems and memory loss are both symptoms of MS, although the underlying causes are not the same as in Alzheimer’s disease.

Pain, another common symptom of MS, may also be alleviated by essential oils such as peppermint, lavender, frankincense, and vanilla, among others. A review of existing research published in December 2017 in International Journal of Molecular Sciences found these oils and others have “therapeutic potential” for a variety of pain conditions.

But most of the studies included in the review involved the use of oils in animals as opposed to human participants.

“It’s a big leap to say that these oils work well in mice so they must work just as well in humans,” Dr. Yadav cautions.

What Are the Potential Downsides of Essential Oils?

Yadav emphasizes that “natural doesn’t always mean safe.” Essential oils are products of an unregulated industry, so the quality and composition of different brands and essences may vary, she says.

In general, it’s best to find an essential oil product that contains only the aromatic plant compound, with no additives or synthetic fragrances. Also, do your research and try to purchase products from a manufacturer with a reputation for quality and safety.

Although aromatherapy is generally safe for people, it may not be for pets. In addition, inhaling certain oils may be harmful for pregnant women and young children.

Finally, essentially oils applied directly to the skin have been known to cause allergic reactions, including rashes, breathing problems, and headaches.

“Don’t overdo it with essential oils, or any other natural remedy,” Ciganovich notes. “It’s important to use these products as directed and not use more, even if it’s working really well. These products, just like prescription meds, can have side effects, so begin slowly to see if they work for you. Also, don’t discontinue your other MS meds without consulting your doctor.”

How to Avoid Imploding When You Have MS

When external pressures build, it’s important to be able to push back with a strong internal sense of self.

By Trevis GleasonJuly 12, 2023

Eye Complications Associated With Multiple Sclerosis

Vision problems are common among people with multiple sclerosis. Learn more about conditions like optic neuritis, nystagmus, and diplopia.

By Ingrid StrauchJuly 11, 2023

6 Hand Exercises for Multiple Sclerosis

These simple hand exercises for MS can help you stretch and strengthen your hands to improve range of motion, grip, and pinch.

By Beth W. OrensteinJuly 10, 2023

The Value of Taking a Tactical Retreat

Having some time to disengage with the struggles of MS is invaluable for our mental health.

By Trevis GleasonJuly 5, 2023

10 Tips for People Newly Diagnosed With Multiple Sclerosis

People diagnosed with multiple sclerosis have many questions and concerns. Get answers and gain insight about your diagnosis, symptoms, treatment, and…

By Jan SheehanJuly 3, 2023

The Importance of Hydration in Multiple Sclerosis

For the blogger Mona Sen, drinking enough water makes a big difference in her fatigue level and in how easily she can move her body.

By Mona SenJune 30, 2023

Uses of Complementary and Alternative Medicine in Multiple Sclerosis

1. Reipert B. Multiple sclerosis: A short review of the disease and its differences between men and women. J Men’s Health Gend. 2004;1:334–40. [Google Scholar]

2. Ganesh A, Apel S, Metz L, Patten S. The case for vitamin D supplementation in multiple sclerosis. Mult Scler Relat Disord. 2013;2:281–306. [PubMed] [Google Scholar]

3. Kostoff RN, Briggs MB, Lyons TJ. Literature-related discovery (LRD): Potential treatments for multiple sclerosis. Technol Forecast Soc Change. 2008;75:239–55. [Google Scholar]

4. Warren KG, Catz I. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. J Neurol Sci. 1993;115:169–76. [PubMed] [Google Scholar]

5. Barten LJ, Allington DR, Procacci KA, Rivey MP. New approaches in the management of multiple sclerosis. Drug Des Devel Ther. 2010;4:343–66. [PMC free article] [PubMed] [Google Scholar]

6. Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B. The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs. Clin Neurol Neurosurg. 2013;115:1271–5. [PubMed] [Google Scholar]

7. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: A systematic review. Eur Neurol. 2013;70:356–63. [PubMed] [Google Scholar]

8. Rodriguez M. Effectors of demyelination and remyelination in the CNS: Implications for multiple sclerosis. Brain Pathol. 2007;17:219–29. [PMC free article] [PubMed] [Google Scholar]

9. Holmøy T. Immunopathogenesis of multiple sclerosis: Concepts and controversies. Acta Neurol Scand Suppl. 2007;115(187):39–45. [PubMed] [Google Scholar]

10. Giovannoni G, Ebers G. Multiple sclerosis: The environment and causation. Curr Opin Neurol. 2007;20:261–8. [PubMed] [Google Scholar]

11. Negahban H, Mofateh R, Arastoo AA, Mazaheri M, Yazdi MJ, Salavati M, et al. The effects of cognitive loading on balance control in patients with multiple sclerosis. Gait Posture. 2011;34:479–84. [PubMed] [Google Scholar]

12. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010;362:402–15. [PubMed] [Google Scholar]

13. Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362:387–401. [PubMed] [Google Scholar]

14. National Center for Complementary and Alternative Medicine. 2000. [Accessed September 11,2000]. Available from:
http://nccam.nih.gov/nccam/fcp/classify . Health NIo, editor.

15. Bowling AC, Ibrahim R, Stewart TM. Alternative medicine and multiple sclerosis: An objective review from an American perspective. Int J MS Care. 2000;2:15–28. [Google Scholar]

16. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] BMC Complement Alternat Med. 2004;4:12. [PMC free article] [PubMed] [Google Scholar]

17. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, et al. Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo-controlled trial. Phytother Res. 2005;19:148–51. [PubMed] [Google Scholar]

18. Brahmachari S, Pahan K. Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol. 2007;179:275–83. [PMC free article] [PubMed] [Google Scholar]

19. Britell C, Burks JS. Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation. New York, NY: Demos Medical Publishing; 2000. Alternative and complementary therapies; pp. 491–504. [Google Scholar]

20. Faix S, Faioxva Z, Placha L, Koppel J. Effect of Cinnamomum zeylanicum essential oil on antioxidative status in broiler chickens. Acta Vet Brno. 2009;78:411–7. [Google Scholar]

21. Ghazavi A, Mosayebi G, Salehi H, Abtahi H. Effect of ethanol extract of saffron (Crocus sativus L.) on the inhibition of experimental autoimmune encephalomyelitis in C57bl/6 mice. Pak J Biol Sci. 2009;12:690–5. [PubMed] [Google Scholar]

22. Gilani AH, Jabeen Q, Khan MA. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak J Biol Sci. 2004;7:441–51. [Google Scholar]

23. Hauser SL, Goodkin D. Multiple sclerosis and other demyelinating diseases. Harrisons Princ Intern Med. 2001;2:2452–61. [Google Scholar]

24. Iriti M, Vitalini S, Fico G, Faoro F. Neuroprotective herbs and foods from different traditional medicines and diets. Molecules. 2010;15:3517–55. [PMC free article] [PubMed] [Google Scholar]

25. Joshi K, Awte S, Bhatnagar P, Walunj S, Gupta R, Joshi S, et al. Cinnamomum zeylanicum extract inhibits proinflammatory cytokine TNF∝: in vitro and in vivo studies. Res Pharm Biotechnol. 2010;2:14–21. [Google Scholar]

26. Kleijnen J. Evening primrose oil. BMJ. 1994;309:824–5. [PMC free article] [PubMed] [Google Scholar]

27. Lee HJ, Hyun EA, Yoon WJ, Kim BH, Rhee MH, Kang HK, et al. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol. 2006;103:208–16. [PubMed] [Google Scholar]

28. Lin KH, Yeh SY, Lin MY, Shih MC, Yang KTu, Hwang SY. Major chemotypes and antioxidative activity of the leaf essential oils of Cinnamomum osmophloeum Kaneh. from a clonal orchard. Food Chem. 2007;105:133–9. [Google Scholar]

29. Millar JH, Zilkha KJ, Langman MJ, Wright HP, Smith AD, Belin J, et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973;1:765–8. [PMC free article] [PubMed] [Google Scholar]

30. Nematollahi M, Majdinasab N, Fakharzade L, Namjooyan F, Latifi S, Pouretezad M. The effect of Nigella sativa seeds on the muscle spasticity of lower limbs in patients with multiple sclerosis. Iran J Neurol. 2013;12(Suppl 1):16. [Google Scholar]

31. Noudeh GD, Sharififar F, Noodeh AD, Hassan M, Moshafi4 MA, Behravan E, et al. Antitumor and antibacterial activity of four fractions from Heracleum persicum Desf. and Cinnamomum zeylanicum Blume. J Med Plants Res. 2010;4:2176–80. [Google Scholar]

32. Rao YK, Fang SH, Tzeng YM. Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. J Ethnopharmacol. 2007;114:78–85. [PubMed] [Google Scholar]

33. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5:1749–70. [PubMed] [Google Scholar]

34. Schultz A. Efficacy of cranberry juice and asorbic acid in acidifying the urine in multiple sclerosis subjects. J Community Health Nurs. 1984;1:159–69. [PubMed] [Google Scholar]

35. Senapati S, Banerjee S, Gangopadhyay DN. Evening primrose oil is effective in atopic dermatitis: A randomized placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2008;74:447–52. [PubMed] [Google Scholar]

36. Smerq J, Sharma M. Possible mechanism of murraya koenigii and cinnamomum tamala with reference to antioxidants activity. Int J Pharm Sci Drug Res. 2011;3:260–4. [Google Scholar]

37. Yu YB, Dosanjh L, Lao L, Tan M, Shim BS, Luo Y. Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PloS One. 2010;5:e9339. [PMC free article] [PubMed] [Google Scholar]

38. Baliga M, Hilditch T. S 18. The constitution of some minor unsaturated fatty acids of rape-seed oils. J Chem Soc (Resumed) 1949:S91–5. [Google Scholar]

39. Bowling AC, Stewart TM. Current complementary and alternative therapies for multiple sclerosis. Curr Treat Options Neurol. 2003;5:55–68. [PubMed] [Google Scholar]

40. Horrobin DF. Multiple sclerosis: The rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses. 1979;5:365–78. [PubMed] [Google Scholar]

41. Brinkeborn RM, Shah DV, Degenring FH. Echinaforce® and other Echinacea fresh plant preparations in the treatment of the common cold: A randomized, placebo controlled, double-blind clinical trial. Phytomedicine. 1999;6:1–6. [PubMed] [Google Scholar]

42. Gunning K. Echinacea in the treatment and prevention of upper respiratory tract infections. West J Med. 1999;171:198–200. [PMC free article] [PubMed] [Google Scholar]

43. Schwarz S, Knauth M, Schwab S, Walter-Sack I, Bonmann E, Storch-Hagenlocher B. Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: A report of two cases. J Neurol Neurosurg Psychiatry. 2000;69:516–8. [PMC free article] [PubMed] [Google Scholar]

44. Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1983;46:854–5. [PMC free article] [PubMed] [Google Scholar]

45. Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler. 2005;11:24–32. [PubMed] [Google Scholar]

46. Embry AF. Vitamin D supplementation in the fight against multiple sclerosis. J Orthomol Med. 2004;19:27–38. [Google Scholar]

47. Mark BL, Carson JA. Vitamin D and autoimmune disease—Implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006;106:418–24. [PubMed] [Google Scholar]

48. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: An update. Eur J Clin Nutr. 2004;58:1095–109. [PubMed] [Google Scholar]

49. van Meeteren ME, Teunissen CE, Dijkstra CD, van Tol EA. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr. 2005;59:1347–61. [PubMed] [Google Scholar]

50. Shinto L, Marracci G, Baldauf-Wagner S, Strehlow A, Yadav V, Stuber L, et al. Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids. 2009;80:131–6. [PMC free article] [PubMed] [Google Scholar]

51. Jaiswal N. Protective effect of flavonoids in multiple sclerosis. J Sci Innov Res. 2013;2:509–11. [Google Scholar]

52. Huntley A, Ernst E. Complementary and alternative therapies for treating multiple sclerosis symptoms: A systematic review. Complement Ther Med. 2000;8:97–105. [PubMed] [Google Scholar]

53. Gaby A. Multiple Sclerosis. Glob Adv Health Med. 2013;2:50–6. [PMC free article] [PubMed] [Google Scholar]

54. Mirshafiey A. Venom therapy in multiple sclerosis. Neuropharmacology. 2007;53:353–61. [PubMed] [Google Scholar]

55. Karimia A, Ahmadi F, Parivar K, Nabiuni M, Haghighi S, Imani S. Effect of honey bee venom on lewis rats with experimental allergic encephalomyelitis, a model for multiple sclerosis. Iran J Pharm Res. 2011;11:671–8. [PMC free article] [PubMed] [Google Scholar]

56. Markelov VV. Bee venom therapy and low dose naltrexone for treatment of multiple sclerosis. Nepal J Neurosci. 2006;3:71–7. [Google Scholar]

57. Esmonde L, Long AF. Complementary therapy use by persons with multiple sclerosis: Benefits and research priorities. Complement Ther Clin Pract. 2008;14:176–84. [PubMed] [Google Scholar]

58. Whitmarsh TE. Homeopathy in multiple sclerosis. Complement Ther Nurs Midwifery. 2003;9:5–9. [PubMed] [Google Scholar]

59. Howarth AL. Will aromatherapy be a useful treatment strategy for people with multiple sclerosis who experience pain? Complement Ther Nurs Midwifery. 2002;8:138–41. [PubMed] [Google Scholar]

60. McGuire C. Acupuncture in the treatment of fatigue in a patient with multiple sclerosis: Case study. Physiotherapy. 2003;89:637–40. [Google Scholar]

61. Hao JJ, Cheng W, Liu M, Li H, Lü X, Sun Z. Treatment of Multiple sclerosis With Chinese scalp Acupuncture. Glob Adv Health Med. 2013;2:8–13. [PMC free article] [PubMed] [Google Scholar]

62. Meyer HB, Katsman A, Sones AC, Auerbach DE, Ames D, Rubin RT. Yoga as an ancillary treatment for neurological and psychiatric disorders: A Review. J Neuropsychiatry Clin Neurosci. 2012;24:152–64. [PubMed] [Google Scholar]

63. Mishra SK, Singh P, Bunch SJ, Zhang R. The therapeutic value of yoga in neurological disorders. Ann Indian Acad Neurol. 2012;15:247–54. [PMC free article] [PubMed] [Google Scholar]

64. Wahbeh H, Elsas SM, Oken BS. Mind–body interventions Applications in neurology. Neurology. 2008;70:2321–8. [PMC free article] [PubMed] [Google Scholar]

65. Chally PS, Carlson JM. Spirituality, rehabilitation, and aging: A literature review. Arch Phys Med Rehabil. 2004;85(Suppl 7):S60–5. [PubMed] [Google Scholar]

66. Kim J, Heinemann AW, Bode RK, Sliwa J, King RB. Spirituality, quality of life, and functional recovery after medical rehabilitation. Rehabil Psychol. 2000;45:365–85. [Google Scholar]

67. Carson EA, Swait G, Johnson IP, Cunliffe C. Chiropractic care amongst people with multiple sclerosis: A survey of MS therapy centres in the UK. Clin Chiropr. 2009;12:23–7. [Google Scholar]

68. Dougherty P, Lawrence D. Chiropractic management of musculoskeletal pain in the multiple sclerosis patient. Clin Chiropr. 2005;8:57–65. [Google Scholar]

69. Roussel AM, Hininger-Favier I, Waters RS, Osman M, Fernholz K, Anderson RA. EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation. Altern Med Rev. 2009;14:56–61. [PubMed] [Google Scholar]

70. Siev-Ner I, Gamus D, Lerner-Geva L, Achiron A. Reflexology treatment relieves symptoms of multiple sclerosis: A randomized controlled study. Mult Scler. 2003;9:356–61. [PubMed] [Google Scholar]

71. Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: Prospects for its integrative management. Altern Med Rev. 2001;6:540–66. [PubMed] [Google Scholar]

72. Bennett M, Heard R. Hyperbaric oxygen therapy for multiple sclerosis. CNS Neurosci Ther. 2010;16:115–24. [PMC free article] [PubMed] [Google Scholar]

73. Fulgenzi A, Zanella SG, Mariani MM, Vietti D, Ferrero ME. A case of multiple sclerosis improvement following removal of heavy metal intoxication. Biometals. 2011;25:569–76. [PubMed] [Google Scholar]

74. Huggins HA, Levy TE. Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal. Altern Med Rev. 1998;3:295–300. [PubMed] [Google Scholar]

75. Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett. 2004;25:211–8. [PubMed] [Google Scholar]

76. Haldane J. Sex hormone treatments for multiple sclerosis. J Orthomol Med. 2012;27:87. [Google Scholar]

77. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002;52:421–8. [PubMed] [Google Scholar]

Identification of essential oils in lippia javanica

Introduction

As part of the implementation of the State Strategy for the Development of the Pharmaceutical Industry of the Russian Federation for the period up to 2030, the priority direction is the production of medicines, including those of plant origin. Interest in herbal medicines remains relevant today due to their mild action, low toxicity and the possibility of long-term use for the prevention and treatment of various diseases. With the development of science and medicine, more and more modern medicines are being created, but medicinal plants are still the main guarantor of the future in medicine and healthcare.

L. javanica is a perennial shrubby, herbaceous plant up to 4.5 m high with strong fragrant leaves that exude lemon flavor when crushed [15-17]. It occurs naturally in central, eastern and southern Africa. In southern Africa, this species grows in Botswana, Malawi, Mozambique, South Africa, Swaziland, Zambia, Zanzibar, and Zimbabwe [15–16].

For many years, the shrub has been used in medical practice in South Africa due to its rich chemical composition, which means it has a wide range of pharmacological activity. The main pharmacological effects include anti-inflammatory, antioxidant, anti-symplastic, anti-microbial, anti-tuberculosis and anti-viral effects, which will allow us to produce better and safer essential oils in the distant future [23-25].

Based on this, the shrub is used to treat a wide range of diseases [28-29]. According to various sources, it is used in the treatment of the following diseases and their symptoms (Table 1).

Table 1. List of diseases and methods of use Lippia Javanica

In medical practice

Based on the data in the table, it can be concluded that Lippia javanica is most often used in the treatment of otolaryngological and pulmonological diseases, which makes its long-term use in the medical field promising in the near future, including the receipt of new sprays and the production of new lozenges from cough, to help people.

Separately, it is worth noting the importance of drugs based on Lippia Javanica in the complex treatment of coronavirus infection (COVID-19). This plant has been widely used for many years in the treatment of infectious diseases, so it is not surprising that the local population of the South African region used essential oils, tinctures, inhalations and decoctions of Lippia Javanica for the prevention, and then in the complex therapy of new strains of COVID-19 [25] . From this it follows a simple conclusion that this medicinal plant opens the possibility for wider research, therefore, mass production of drugs against microbes and viruses will be launched in the near future, since the plant contains polyphenols and flavonoids, which have such effects.

The composition of essential oils varies considerably depending on the place of origin, harvest season and weather. The complex molecular composition of many essential oils requires high resolution separation in order to characterize the range of compounds that make up the oils. In addition, it is often necessary to study small differences between oils that correspond to differences in the geographic or genetic origin of the plant material.

Chromatography, especially gas chromatography (GC) and mass spectroscopy (MS), have been the most widely used analytical methods for analyzing essential oils. However, the limitations of GC and GC/MS have pushed chromatographers to search in depth for more efficient methods for analyzing essential oil volatiles, such as improved sample preparation prior to injection. The methods tested were steam distillation, dynamic headspace, static headspace and SPME (solid phase microextraction). As a result, the static headspace method (SPHX) is now the leading sampling method.

It is important to note that GC analysis of essential oils is usually done to evaluate a particular plant or herb for oil percentage and components. However, the analytical values ​​obtained in this way are not directly related to the volatiles in the herb itself, and may not correctly reflect the actual quality of the herb, depending on the isolation technique used. However, using a method such as the static headspace method in GC only allows you to get a profile of essential oils.

Mass spectrometry (MS) can be defined as the study of systems by the formation of gaseous ions with or without fragmentation, which are then characterized by mass-to-charge ratio (m/z) and relative amounts [41]. The analyte can be ionized thermally, by an electric field, or by exposure to high energy electrons, ions, or photons.

The last decade has seen a tremendous growth in the popularity of mass spectrometers as instruments for both standard analytical experiments and fundamental research. This is due to a number of features, including relatively low cost, simple design, and extremely high data acquisition rates. And, although the sample is destroyed by the mass spectrometer in the process, this method is very sensitive, and only a small amount of material is used in the analysis.

However, as is well known, compounds such as isomers can be misidentified by GC-MS analysis; this shortcoming is often observed in the analysis of essential oils. It is widely known that the composition of essential oils is mainly represented by terpenes, which give very similar mass spectra; therefore, a favorable match ratio is not sufficient for identification, and peak assignment becomes a difficult, if not impossible, task.

On the other hand, provided that the data contained in the mass spectrum libraries were recorded using genuine samples, it can be seen that the mass spectrum of a single terpene is usually sufficient to allow its identification in combination with the retention index obtained from methyl silicone stationary phases.

Materials and methods

The object of the study was the herb Lippia Javanica. To determine the optimal results, pharmacognostic analysis, macroscopic analysis, microscopic analysis, quantitative analysis of essential oil and its qualitative analysis were carried out. Determination of the essential oil content was carried out by steam distillation of Verbena Officinalis herb and Lippia Javanica herb followed by volume measurement. The mass fraction was expressed as a percentage of the ratio of mass to volume based on absolutely dry raw material or preparation. For the experiment, Method 2 of the RF Pharmacopoeia .1.5.3.0010.15 “Determination of the content of essential oil in medicinal plant raw materials and medicinal herbal preparations” was used. Materials used: distilled water, 10% sodium hydroxide solution, glycerin, essential oil measurement equipment, analytical balance, microscopy, Petri dishes. 50 grams of ground Verbena Officinalis and Lippia Javanica, respectively, were weighed on an analytical balance. The sample was placed in a round bottom flask, where 500 ml of distilled water was added. The steam distillation process of the essential oil took two hours.

All data were acquired using the following equipment:

– TriPlus 500 PF autosampler (Thermo Scientific)

– TRACE 1300 gas chromatograph (Thermo Scientific)

– MS detection with ISQ 7000 (Thermo Scientific) 90 005

– PC workstation with Chromeleon CDS ver. 7.2.10

– MS NIST Library 16

Separation was carried out on a capillary column TraceGold 5 30 m x 0.32 mm x 0.25 mm (Thermo Scientific) in a programmed temperature mode.

Headspace parameters:

GC parameters:

MS parameters:

Peak identification provided by NIST Library 16 MS.

Results and Discussions

The result of pharmacognostic analysis is represented by microscopic features, including stomata, etherovascular glands, and short simple unicellular hairs shown in fig. 1-3.

Qualitative analysis revealed the presence of essential oil in the herb L. javanica. The collected volume reached about 20 ml. It did not have a viscous and oily consistency; most likely, Lippia Javanica essential oils are thermolabile. The result was a watery liquid with a characteristic strong odor and taste, Figure 4.

Qualitative analysis for other active substances was carried out within 30 minutes. The following reagents were used: ammonia 10%, sodium hydroxide 10%, ammonium ferrous sulfate, sodium molybdate, ferric chloride.

Figure 2. Lippia Javanica raw material under the microscope (1 – Essential oil cavities)

glandular simple unicellular hairs).

Figure 4. Organoleptic testing of essential oils Lippia Javanica

A qualitative analysis of possible active compounds was also carried out. L. javanica showed flavonoids when reacted with 10% ammonia, a yellow color and a pale yellow color with 10% sodium hydroxide solution. Yellow coloration with iron and ammonium sulfate indicates the presence of tannins. Dark green staining with ferric chloride showed the presence of phenol and flavonoids in both plants. Lippia Javanica gave a pale red color with sodium molybdate indicating the presence of phenols.

Crude essential oil from Lippia Javanica was extracted by steam distillation. Crude oil was placed in a 20 ml tube and sealed. The total ion chromatogram (SIC) obtained under the above conditions is shown in fig. 1.

Signals of 54 components were registered on the chromatogram. Some of the peaks, especially at the end of the chromatogram, were identified as components of the stationary liquid phase. Most of the minor components are identified as esters of C4-C10 alcohols and C2-C5 acids, as well as benzoic acid. Several minor peaks have been identified as simple terpenes such as geraniol, pinene and cineole. The main components were identified as benzoic acid (peak at 7.298), phenylmethyl benzoate (peak at 15.671), ethyllinolaol (peak at 16.581) and its cis isomer (peak at 16.690), mequinol (peak at 18.093), piperonal (peak at 18.442), isocitroneol, and corimbolone (peaks at 22.827 and 23.300, respectively). ). The results of the search in the MS library are shown in fig. 2.

Conclusions.

The chemical classification of essential oils has been carried out. The features of the chemical structure, and physico-chemical properties of essential oils are described.

Lippia Javanica has been reported in the literature as being used as an additive to other medicines to fight the coronavirus (COVID-19) in the South African region.

This scientific study presents a method for determining the content of essential oil, describes its quantitative assessment and assessment of the quality of raw materials. The study is ideally suited for practical application and will help in the near future to expand the field of medicine and pharmaceuticals through the introduction of such essential oils, obtained in the cheapest and most effective ways.

The study takes into account the appearance, geographical distribution and habitats of Lippia Javanica containing essential oils. The idea is to import a medicinal plant from South Africa at a lower cost and produce more drugs here in the Russian Federation, or build a pharmaceutical manufacturing company in Zimbabwe to produce high quality and safe essential oils for the local population. It has been found that L. javanica contains higher quality essential oils, which gives a positive result in the development of the concept for the production of medicinal and cosmetic essential oils of higher quality and safety for the population.

Literature review and practice showed that L. javanica has heat labile essential oils, but they lack viscosity and oily consistency, and research will be done with another way to isolate heat labile essential oils. An alternative method can be used to develop the production of essential oils from Lippia javanica individually or through grants.

In addition, macro- and microscopic signs were taken into account, and all possible diagnostic signs for Lippia Javanica were confirmed. Qualitative analysis showed that L. javanica contains flavonoids, tannins, and phenols, which manifests itself as a pale red color when interacting with sodium molybdate.

In this regard, the composition of the essential oil of L. javanica was studied by PF-GC-MS, which showed that the essential oil is composed of more than 50 compounds of terpenes, ethers, aldehydes and aromatic acids.

Thus, Lippia Javanica can be introduced into medical practice as a source of essential oils and other phytochemicals due to its medicinal value. Research needs to be done and then patented or sold to major pharmaceutical companies so that they can produce more essential oils and other drugs such as NSAIDs[1] based on Lippia javanica.

[1] Nonsteroidal anti-inflammatory drugs

Files:

• TRANSLATION_IDENTIFICATION_OF_ESSENTIAL_OILS_IN_LIPPIA_JAVANICA.pdf

• IDENTIFICATION_OF_ESSENTIAL_OILS_IN_LIPPIA_JAVANICA.pdf

Antifungal potential of Mentha piperita and Cinnamomum verum essential oils | Sharma

1. Khanam S.J.P., Jain P.C. Isolation of keratin degrading fungi from soil of Damoh (India). Asian Journal of Microbiology, Biotechnology and Environmental Sciences. 2002;4(2):251-254.

2. Mukesh S., Sharma M. Incidence of dermatophytes and other keratinophilic fungi in the schools and college playground soils of Jaipur, India. African Journal of Microbiology Research. 2010;4(24):2647-2654.

3. Marsella R., Mercantini R. Keratinophilic fungi isolated from soils of the Abruzzo National Park Italy. Mycopathology. 2013;94(2):97-107.

4. Dominik T., Majchrowicz I. A trial for isolating keratinolytic and keratinophilic fungi from the soils of the cemeteries and forests of Szczecin. Ekologia Polska – Seria A. 1964;12:79-105.

5. Ajello L. The dermatophytes, Microsporum gypseum as a saprophyte and parasite. Journal of Investigative Dermatology. 1953;21(3):157-171. https://doi.org/10.1038/jid.1953.86.

6. AI-Doory Y. The occurrence of keratinophilic fungi in Texas soil. Mycopathol Mycol Appl. 1967;33:105-112. http://doi.org/10.1007/BF02053441.

7. Karam EI-Din A.A., Youssef A.Y., Zaki S. Distribution of pathogenic and potentially pathogenic fungi among soil fungal flora in Egypt. African Journal of Mycology and Biotechnology. 1996;4:23-39.

8. Hedayati M.T., Mohseni-Bandpi A., Moradi S. A survey on the pathogenic fungi in soil samples of potted plants from Sari hospitals, Iran. Journal of Hospital Infection. 2004;58(1):59-62. http://doi.org/10.1016/j. jhin.2004.04.011.

9. Ramesh V.M., Hilda A. Incidence of keratinophilic fungi in the soil of primary schools and public parks of Madras City, India. Mycopathol Mycol Appl. 1998;143:139-145. http://doi.org/10.1023/a:1006945012620.

10. Papini R., Mancianti F., Grassott G., Cardini G. Survey of keratinophilic fungi isolated from city park soils of Pisa, Italy. Mycopathol Mycol Appl. 1998;143(1):17-123. http://doi.org/10.1023/a:1006919707839.

11. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control & Hospital Epidemiology. 2008;29(11):996-1011. http://doi.org/10.1086/591861.

12. Mayrhofer S., Paulsen P., Smulders F.J.M., Hilbert F. Antimicrobial resistance profile of five major food-borne pathogens isolated from beef, pork and poultry. International Journal of Food Microbiology. 2004;97(1):23-29. http://doi.org/10.1016/j.ijfoodmicro.2004.04.006.

13. Zomorodian K., Haghighi N.N., Rajaee N., Pakshir K., Tarazooie B., Vojdhani M., et al. Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. medical mycology. 2011;49(2):208-211. http://doi.org/10.3109/13693786.2010.507605.

14. Chevalier M., Medioni E., Precheur I. Inhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts. Journal of Medical Microbiology. 2012;61(7):1016-1022. http://doi.org/10.1099/jmm.0.041699-0.

15. Sara B. Essential oils: their antibacterial properties and potential applications in foods – a review. International Journal of Food Microbiology. 2004;94:223-253. http://doi.org/10.1016/j.ijfoodmi-cro.2004.03.022.

16. Ahmet C., Saban K., Hamdullah K., Ercan K. Antifungal properties of essential oils and crude extracts of Hypericum linarioides Bosse. Biochemical Systematics and Ecology. 2005;33(3):245-256. http://doi.org/10.1016/j.bse.2004.08.006.

17. Tiwari R.D., Shrestha A.K. Antifungal activity of crude extracts of some medicinal plants against Fusarium solanai (Mart.) Sacc. Ecoprint: An International Journal of Ecology. 2009;16:75-78. https://doi.org/10.3126/eco.v16i0.3476.

18. Mishra A.K., Dubey N.K. Evaluation of some essential oils for their toxicity against fungi causing deterioration of stored food commodities. Applied and Environmental Microbiology. 1994;60(4):1101-1105. http://doi.org/10.1128/aem.60.4.1101-1105.1994.

19. Bagamboula C.F., Uyttendaele M., Debevere J. Inhibitory effect of thyme and basil essential oils, carvacrol, thymol, estragol, linalool and p-cymene towards Shigella sonnei and S. flexneri. food microbiology. 2004;21(1):33-42. https://doi.org/10.1016/S0740-0020(03)00046-7.

20. White T.C., Holleman S., Mirels L.F., Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrobial Agents and Chemotherapy. 2002;46(6):1704-1713. http://doi.org/10.1128/AAC.46.6.1704-1713.2002.

21. Moreira M.R., Ponce A.G., del Valle C.E., Roura S.I. Inhibitory parameters of essential oils to reduce a food-borne pathogen. Lebensmittel-Wissenschaft & Technologie. 2005;38(5):565-570. https://doi.org/10.1016/j.lwt.2004.07.012.

22. Souza E.L., de Barros J.C., de Olivieria C.E.V., da Conceicao M.L. Influence of Origanum vulgare L. essential oil on enterotoxin production, membrane permeability and surface characteristics of Staphylococcus aureus. International Journal of Food Microbiology. 2010;137(2-3):308-311. http://doi.org/10.1016/j.ijfoodmicro.2009.11.025.

23. Derwich E., Benziane Z., Taouil R., Senhaji O., Touzani M. Aromatic plants of morocco: GC/MS analysis of the essential oils of leaves of Mentha piperita. Advances in Environmental Biology. 2010;4(1):80-85.

24. Tyagi A.K., Malik A. Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: microscopic observations and chemical characterization of Cymbopogon citratus. BMC Complementary and Alternative Medicine. 2010;10:65. http://doi.org/10.1186/1472-6882-10-65.

25. Sandasi M., Leonard C.M., Viljoen A.M. The in vitro antibiofilm activity of selected culinary herbs and medicinal plants against Listeria monocytogenes. Letters in Applied Microbiology. 2010;50(1):30-35. http://doi.org/10.1111/j.1472-765X.2009.02747.x.

26. Baliga M., Rao S. Radioprotective potential of mint: a brief review. Journal of Cancer Therapeutics and Research. 2010;6(3):255-262. http://doi/10.4103/0973-1482.73336.

27. Nabavi S.M., Marchese A., Izadi M., Curti V., Daglia M., Nabavi S.F. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. food chemistry. 2015;173:339-347. http://doi.org/10.1016/j.foodchem.2014.10.042.

28. Hogberg L.D., Heddini A., Cars O. The global need for effective antibiotics: Challenges and recent advances. Trends in Pharmacological Sciences. 2010;31(11):509-515. http://doi.org/10.1016/j.tips. 2010.08.002.

29. Wong Y.C., Ahmad-Mudzaqqirand M.Y., Wan-Nurdiyana W.A. Extraction of essential oil from Cinnamon (Cinnamomum zeylanicum). Oriental Journal of Chemistry. 2014;30(1):37-47. http://doi.org/10.13005/ojc/300105.

30. Muchuweti M., Kativu E., Mupure C.H., Chidewe C., Ndhlala A.R., Benhura M.A.N. Phenolic composition and antioxidant properties of some spices. American Journal of Food Technology. 2007;2(5):414-420. http://doi.org/10.3923/ajft.2007.414.420.

31. Chevalier M., Medioni E., Precheur I. Inhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts. Journal of Medical Microbiology. 2012;61(7):1016-1022. http://doi.org/10.1099/jmm.0.041699-0.

32. Saharkhiz M.J., Ghani A., Khayat M. Changes in essential oil composition of Clary sage (Salvia sclarea L.) aerial parts during its phenological cycle. Medicinal and Aromatic Plant Science and Biotechnology. 2009; 3:90-93.

33. Vanbreuseghem R. Technique biologique pour 1 isolement des dermatophytes du soil. Annales de la Societe belge de medecine tropicale. 1952;32:173-178.

34. Sharma G., Sharma R., Saxena R., Rajni E. Synergistic, antidermatophytic activity and chemical composition of essential oils against zoonotic dermatophytosis. Russian Journal of Bioorganic Chemistry. 2022;48:1338-1347. https://doi.org/10.1134/S1068162022060218.

35. Gould J.C., Bowie J.H. The determination of bacterial sensitivity to antibiotics. Edinburgh Medical Journal. 1952;59(4):178-199.

36. Deshmukh S.K., Agrawal S.C. Degradation of human hair by some dermatophytes and other keratinolphilic fungi. Myksosen. 1982;25(8):463-466. http://doi.org/10.1111/j.1439-0507.1982.tb01965.x.

37. Shadzis S., Chadeganipour M., Alimoradi M. Isolation of keratinophilic fungi from elementary schools and public parks in Isfahan, Iran. mycoses. 2002;45(11-12):496-499. https://doi.org/10.1046/j.1439-0507.2002.00798.x.

38. Shukia P. , Shukla C.B., Kango N., Shukla A. Isolation and characterization of a dermatophyte, Microsporum gypseum from poultry farm soils of Rewa (Madhya Pradesh), India. Pakistan Journal of Biological Sciences. 2003;6(6):622-625. https://doi.org/10.3923/pjbs.2003.622.625.

39. Sharma R., Rajak R.C. Keratinophilic fungi: Nature’s keratin degrading machines. Their isolation identification and ecological role. resonance. 2003;8:28-40. http://doi.org/10.1007/BF02837919.

40. Marchisio M.V. Keratinophilic fungi: their role in nature and degradation of keratinic substrates. In: Biology of dermatophytes and other keratinophilic fungi. 2000; vol. 7, p. 77-85.

41. Cabanes F.J. Emerging mycotoxins: introduction. Review Iberoam Mycologia. 2002;17(2):S61-S62.

42. Baranova Z., Kozak M., Bilek J. Zoophilic dermatomycosis in a family caused by Trichophyton mentagrophytes var. quincheanum – A case report. Acta Veterinaria Brno. 2003;72(2):311-314. https://doi.org/10.2754/avb200372020313.

43. Ali-Shtayeh M.S. Keratinophilic fungi isolated from childrens sandpits in the Nablus area west bank of Jordan. Mycopathology. 1988;103:141-146. http://doi.org/10.1007/BF00436812.

44. Ramesh V.M., Hilda A. Incidence of keratinophilic fungi in the soil of primary schools and public parks of Madras City, India. Mycopathology. 1998;143(3):139-145. http://doi.org/10.1023/a:1006945012620.

45. Gianni C., Cerri A., Crostic C. Non-dermatophytic onychomycosis. N underestimated entity? A study of 51 cases. mycoses. 2000;43(1-2):29-33. http://doi.org/10.1046/j.1439-0507.2000.00547.x.

46. Hofling J.F., Anibal P.C., Obando-Pereda G.A., Peixoto I.A.T., Furletti V.F., Foglio M.A., et al. Antimicrobial potential of some plant extracts against Candida species. Brazilian Journal of Biology. 2010;70(4):1065-1068. http://doi.org/10.1590/s1519-69842010000500022.

47. Unlu M., Ergene E., Unlu G.V., Zeytinoglu H.S., Vural N. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food Chemical Toxicol. 2010;48(11):3274-3280. http://doi.org/0.1016/j.fct.2010.09.001.

48. Gende L.B., Floris I., Fritz R., Eguaras M.J. Antimicrobial activity of cinnamon (Cinnamomum zeylanicum) essential oil and its main components against Paenibacillus larvae from Argentine. Bulletin of Insectology. 2008;61(1):1-4.

49. Wuthi-Udomlert M., Grisanapa W., Luanratana O., Caichompoo W. Antifungal activity of Curcuma longa grown in Thailand. Southeast Asian Journal of Tropical Medicine. 2000;31(1):178-182.

50. Falahati M., Tabrizib N.O., Jahaniani F. Antidermatophyte activities of Eucalyptus canalduensis in comparison with griseofulvin. Iranian Journal of Pharmacology and Therapeutics. 2005;4:80-83.

51. Sharma R., Sharma G.N., Sharma M. Additive and inhibitory effect of antifungal activity of Curcuma longa (Turmeric) and Zingiber officinale (Ginger) essential oils against Pityriasis versicolor infections. Journal of Medicinal Plants. 2011;5(32):6987-6990. http://doi.org/10.5897/JMPR11.1032.

52. Chin Y.W., Balunas M.J., Chai H.B., Kinghorn A.D. Drug discovery from natural sources. AAPS Journal. 2006;8(2):E239-E253. http://doi.org/10.1007/BF02854894.

53. Harvey A.L. Natural products as a screening resource. Current Opinion in Chemical Biology. 2007;11(5):480-484. http://doi.org/10.1016/j.cbpa.2007.08.012.

54. Jayaprakasha G.K., Rao L.J.M., Sakariah K.K. Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities. Journal of Agricultural and Food Chemistry. 2003;51:4344-4348. http://doi.org/10.1021/jf034169i.

55. Al-Ali S., Al-Judaibi A. Effect of natural products and essentials oils on pathogenic fungi. Acta Scientific Microbiology. 2019;2(6):2581-3226. http://doi.org/10.31080/ASMI.2019.02.0255.

56. Kizil S., Ha§imi N., Tolan V., Kiling E., Yuksel U. Mineral content, essential oil components and biological activity of two mentha species (M. piperita L., M. spicata L. ). Turkish Journal of Field Crops. 2010;15(2):148-153. http://doi.org/10.17557/TJFC.56629.

57. Lima B., Lopez S., Luna L., Aguero M.B., Aragon L., Tapia A., et al. Essential oils of medicinal plants from the central andes of Argentina: chemical composition, and antifungal, antibacterial, and insect-repellent activities. Chemistry & Biodiversity. 2011;8(5):924-936. http://doi.org/10.1002/cbdv.201000230.

58. Agarwal V., Lal P., Pruthi V. Prevention of Candida albicans biofilm by plant oils. Mycopathology. 2008;165(1):13-19. http://doi.org/10.1007/s11046-007-9077-9.

59. Shiming Li., Lo C.Y., Ho C.T. Hydronylated polymrthoxplavones and mentholated flavonoid in sweel orange peel. Journal of Agricultural and Food Chemistry. 2006;54(12):4176-4185. http://doi.org/10.1021/jf060234n.

60. Trombetta D., Castelli F., Sarpietro M.G. Mechanisms of antibacterial action of three monoterpenes. Antimicrobial Agents and Chemotherapy. 2005;49(6):2474-2478. http://doi.org/10.